Macrophages are important determinants of acute ocular HSV-1 infection in immunized mice

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 12, 2007, Pages 5605-5615

  Mott, Kevin ^a   Brick, David J ^b   Van Rooijen, Nico ^c   Ghiasi, Homayon ^a  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CLODRONIC ACID; DNA VACCINE; GLYCOPROTEIN B; GLYCOPROTEIN D; GLYCOPROTEIN E; GLYCOPROTEIN I; HERPES SIMPLEX VACCINE; LATENCY ASSOCIATED TRANSCRIPT PROTEIN; PROTEIN C; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; CYTOKINE; DRUG DERIVATIVE; FREUND ADJUVANT; MANNITOL; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEPHARITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LOSS; CONTROLLED STUDY; DERMATITIS; DNA IMMUNIZATION; DRUG EFFECT; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNIZATION; LATENT PERIOD; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TRIGEMINUS GANGLION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CORNEA ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; METABOLISM; MORTALITY; PHYSIOLOGY; VACCINATION; VIROLOGY; VIRUS LATENCY;

ACUTE DISEASE; ANIMALS; ANTIBODIES, VIRAL; BLEPHARITIS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FREUND'S ADJUVANT; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; KERATITIS, DENDRITIC; MACROPHAGES; MANNITOL; MICE; MICE, INBRED BALB C; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 38549148401     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0894     Document Type: Article

References (57)

1. Macatonia SE, Hsieh CS, Murphy KM, O'Garra A. Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent. Int Immunol. 1993;5:1119-1128.
2. Morahan PS, Morse SS, McGeorge MG. Macrophage extrinsic antiviral activity during herpes simplex virus infection. J Gen Virol. 1980;46:291-300.
3. Ramirez MC, Sigal LJ. Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J Immunol. 2002;169:6733-6742.
4. Sit MF, Tenney DJ, Rothstein JL, Morahan PS. Effect of macrophage activation on resistance of mouse peritoneal macrophages to infection with herpes simplex virus types 1 and 2. J Gen Virol. 1988;69:1999-2010.
5. Young HA, Hardy KJ. Role of interferon-gamma in immune cell regulation. J Leukoc Biol. 1995;58:373-381.
6. Peters JH, Gieseler R, Thiele B, Steinbach F. Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today. 1996;17:273-278.
7. Tumpey TM, Chen SH, Oakes JE, Lausch RN. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol. 1996;70:898-904.
8. Berra A, Rodriguez A, Heiligenhaus A, Pazos B, Van Rooijen N, Foster CS. The role of macrophages in the pathogenesis of HSV-1 induced chorioretinitis in BALB/c mice. Invest Ophthalmol Vis Sci. 1994;35:2990-2998.
9. Ghiasi H, Wechsler SL, Kaiwar R, Nesburn AB, Hofman FM. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1. J Virol. 1995;69:334-340.
10. Ghiasi H, Hofman FM, Cai S, Perng GC, Nesburn AB, Wechsler SL. Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated mice. Vaccine. 1999;17:2576-2582.
11. Yan XT, Tumpey TM, Kunkel SL, Oakes JE, Lausch RN. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest Ophthalmol Vis Sci. 1998;39:1854-1862.
12. Tumpey TM, Cheng H, Cook DN, Smithies O, Oakes JE, Lausch RN. Absence of macrophage inflammatory protein-1 alpha prevents the development of blinding herpes stromal keratitis. J Virol. 1998;72:3705-3710.
13. Esiri MM, Drummond CW, Morris CS. Macrophages and microglia in HSV-1 infected mouse brain. J Neuroimmunol. 1995;62:201-205.
14. Ikeda S, Negishi T, Nishimura C. Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs. Antiviral Res. 1985;5:207-215.
15. Horn M, Schlote W, Herrmann G, Gungor T, Jacobi G. Immunocytochemical characterization of cytomegalovirus (CMV) infected giant cells in perinatal acquired human immunodeficiency virus (HIV) infection. Acta Histochem Suppl. 1992;42:115-122.
16. Hofman FM, Lopez D, Husmann L, Meyer PR, Taylor CR. Heterogeneity of macrophage populations in human lymphoid tissue and peripheral blood. Cell Immunol. 1984;88:61-74.
17. Tumpey TM, Cheng H, Yan XT, Oakes JE, Lausch RN. Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. J Leukoc Biol. 1998;63:486-492.
18. D'Andrea A, Rengaraju M, Valiante NM, et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med. 1992;176:1387-1398.
19. Schwarz T. Interleukin-12 and its role in cutaneous sensitization. Res Immunol. 1995;146:494-499.
20. Chan SH, Perussia B, Gupta JW, et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med. 1991;173:869-879.
21. Brunda MJ. Interleukin-12. J Leukoc Biol. 1994;55:280-288.
22. Godfrey DI, Kennedy J, Gately MK, Hakimi J, Hubbard BR, Zlotnik A. IL-12 influences intrathymic T cell development. J Immunol. 1994;152:2729-2735.
23. Tran MT, Tellaetxe-Isusi M, Elner V, Strieter RM, Lausch RN, Oakes JE. Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells: beta-chemokine synthesis in corneal cells. Invest Ophthalmol Vis Sci. 1996;37:987-996.
24. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes. J Clin Lab Immunol. 1990;32:161-166.
25. Barsig J, Flesch IE, Kaufmann SH. Macrophages and hepatocytic cells as chemokine producers in murine listeriosis. Immunobiology. 1998;199:87-104.
26. Flesch IE, Barsig J, Kaufmann SH. Differential chemokine response of murine macrophages stimulated with cytokines and infected with Listeria monocytogenes. Int Immunol. 1998;10:757-765.
27. Osorio Y, Cohen J, Ghiasi H. Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines. Invest Ophthalmol Vis Sci. 2004;45:506-514.
28. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of TH1 CD4+ T cells through IL-12 produced by listeria-induced macrophages. Science. 1993;260:547-549.
29. Macatonia SE, Hosken NA, Litton M, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol. 1995;154:5071-5079.
30. Guler ML, Gorham JD, Hsieh CS, et al. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science. 1996;271:984-987.
31. Ghiasi H, Cai S, Slanina SM, Perng GC, Nesburn AB, Wechsler SL. The Role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease. J Infect Dis. 1999;179:1086-1093.
32. Ghiasi H, Wechsler SL, Cai S, Nesburn AB, Hofman FM. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology. 1998;95:352-359.
33. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174:83-93.
34. Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol. 1994;68:2118-2126.
35. Ghiasi H, Bahri S, Nesburn AB, Wechsler SL. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest Ophthalmol Vis Sci. 1995;36:1352-1360.
36. Rock DL, Nesburn AB, Ghiasi H, et al. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J Virol. 1987;61:3820-3866.
37. Dobson AT, Margolis TP, Sedarati F, Stevens JG, Feldman LT. A latent, nonpathogenic HSV-1-derived vector stably expresses beta- galactosidase in mouse neurons. Neuron. 1990;5:353-360.
38. Wechsler SL, Nesburn AB, Watson R, Slanina SM, Ghiasi H. Fine mapping of the latency-related gene of herpes simplex virus type 1 : alternative splicing produces distinct latency-related RNAs containing open reading frames. J Virol. 1988;62:4051-4058.
39. Fraser NW, Block TM, Spivack JG. The latency-associated transcripts of herpes simplex virus: RNA in search of function. Virology. 1992;191:1-8.
40. Thomas J, Gangappa S, Kanangat S, Rouse BT. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol. 1997;158:1383-1391.
41. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science. 1996;272:50-53.
42. Heiligenhaus A, Bauer D, Zheng M, Mrzyk S, Steuhl KP. CD4+ T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea. Graefes Arch Clin Exp Ophthalmol. 1999;237:399-406.
43. Babu JS, Kanangat S, Rouse BT. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J Immunol. 1995;154:4822-4829.
44. Tumpey TM, Elner VM, Chen SH, Oakes JE, Lausch RN. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J Immunol. 1994;153:2258-2265.
45. Bauer D, Schmitz A, Van Rooijen N, Steuhl KP, Heiligenhaus A. Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection. Immunology. 2002;107:118-128.
46. Cheng H, Tumpey TM, Staats HF, van Rooijen N, Oakes JE, Lausch RN. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest Ophthalmol Vis Sci. 2000;41:1402-1409.
47. Ghiasi H, Hofman FM, Wallner K, et al. Corneal macrophage infiltrates following ocular herpes simplex virus type 1 challenge vary in BALB/c mice vaccinated with different vaccines. Vaccine. 2000;19:1266-1273.
48. Bauer D, Mrzyk S, Van Rooijen N, Steuhl KP, Heiligenhaus A. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages. Exp Eye Res. 2001;72:261-269.
49. Bauer D, Mrzyk S, van Rooijen N, Steuhl KP, Heiligenhaus A. Macrophage-depletion influences the course of murine HSV-1 keratitis. Curr Eye Res. 2000;20:45-53.
50. Kodukula P, Liu T, Rooijen NV, Jager MJ, Hendricks RL. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J Immunol. 1999;162:2895-2905.
51. Hirsch MS, Zisman B, Allison AC. Macrophages and age-dependent resistance to Herpes simplex virus in mice. J Immunol. 1970;104:1160-1165.
52. Wijburg OL, Heemskerk MH, Boog CJ, Van Rooijen N. Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59. Immunology. 1997;92:252-258.
53. Zisman B, Wheelock EF, Allison AC. Role of macrophages and antibody in resistance of mice against yellow fever virus. J Immunol. 1971;107:236-243.
54. Ben-Nathan D, Huitinga I, Lustig S, van Rooijen N, Kobiler D. West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch Virol. 1996;141:459-469.
55. Ghiasi H, Roopenian DC, Slanina S, Cai S, Nesburn AB, Wechsler SL. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge. Immunology. 1997;91:430-435.
56. Dawson CR. Ocular herpes simplex virus infections. Clin Dermatol. 1984;2:56-66.
57. Barron BA, Gee L, Hauck WW, et al. Herpetic Eye Disease Study: a controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 1994;101:1871-1882.